CLP1 Founder Mutation Links tRNA Splicing and Maturation to Cerebellar Development and Neurodegeneration
Author(s) -
Ashleigh E. Schaffer,
Veerle Rc Eggens,
Ahmet Okay Çağlayan,
Miriam S. Reuter,
Eric Scott,
Nicole G. Coufal,
Jennifer L. Silhavy,
Yuanchao Xue,
Hülya Kayserili,
Katsuhito Yasuno,
Rasim Özgür Rosti,
Mostafa Abdellateef,
Caner Çağlar,
Paul R. Kasher,
J. Leonie Cazemier,
Marian A. J. Weterman,
Vincent Cantagrel,
Na Cai,
Christiane Zweier,
Umut Altunoğlu,
N. Bilge Satkin,
Fesih Aktar,
Beyhan Tüysüz,
Cengiz Yalçınkaya,
Hüseyîn Çaksen,
Kaya Bilgüvar,
XiangDong Fu,
Christopher Trotta,
Stacey Gabriel,
André Reis,
Murat Günel,
Frank Baas,
Joseph G. Gleeson
Publication year - 2014
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2014.03.049
Subject(s) - biology , neurodegeneration , genetics , transfer rna , mutation , gsk 3 , rna splicing , microbiology and biotechnology , gene , rna , kinase , medicine , disease
Neurodegenerative diseases can occur so early as to affect neurodevelopment. From a cohort of more than 2,000 consanguineous families with childhood neurological disease, we identified a founder mutation in four independent pedigrees in cleavage and polyadenylation factor I subunit 1 (CLP1). CLP1 is a multifunctional kinase implicated in tRNA, mRNA, and siRNA maturation. Kinase activity of the CLP1 mutant protein was defective, and the tRNA endonuclease complex (TSEN) was destabilized, resulting in impaired pre-tRNA cleavage. Germline clp1 null zebrafish showed cerebellar neurodegeneration that was rescued by wild-type, but not mutant, human CLP1 expression. Patient-derived induced neurons displayed both depletion of mature tRNAs and accumulation of unspliced pre-tRNAs. Transfection of partially processed tRNA fragments into patient cells exacerbated an oxidative stress-induced reduction in cell survival. Our data link tRNA maturation to neuronal development and neurodegeneration through defective CLP1 function in humans.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom